- Home
- IRWD vs ARMN Comparison
IRWD vs ARMN Comparison
Compare IRWD & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- ARMN
- Stock Information
- Founded
- IRWD 1998
- ARMN 1992
- Country
- IRWD United States
- ARMN Canada
- Employees
- IRWD N/A
- ARMN N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- ARMN
- Sector
- IRWD Health Care
- ARMN
- Exchange
- IRWD Nasdaq
- ARMN Nasdaq
- Market Cap
- IRWD 716.9M
- ARMN 834.4M
- IPO Year
- IRWD 2010
- ARMN N/A
- Fundamental
- Price
- IRWD $4.44
- ARMN $4.64
- Analyst Decision
- IRWD Buy
- ARMN
- Analyst Count
- IRWD 4
- ARMN 0
- Target Price
- IRWD $12.00
- ARMN N/A
- AVG Volume (30 Days)
- IRWD 1.5M
- ARMN 1.1M
- Earning Date
- IRWD 11-07-2024
- ARMN 11-13-2024
- Dividend Yield
- IRWD N/A
- ARMN N/A
- EPS Growth
- IRWD N/A
- ARMN N/A
- EPS
- IRWD 0.06
- ARMN 0.09
- Revenue
- IRWD $400,565,000.00
- ARMN $466,257,000.00
- Revenue This Year
- IRWD N/A
- ARMN $46.47
- Revenue Next Year
- IRWD $2.80
- ARMN N/A
- P/E Ratio
- IRWD $78.45
- ARMN $61.56
- Revenue Growth
- IRWD N/A
- ARMN 15.56
- 52 Week Low
- IRWD $3.79
- ARMN $2.32
- 52 Week High
- IRWD $15.70
- ARMN $5.16
- Technical
- Relative Strength Index (RSI)
- IRWD 52.71
- ARMN 52.87
- Support Level
- IRWD $4.06
- ARMN $4.39
- Resistance Level
- IRWD $4.39
- ARMN $4.55
- Average True Range (ATR)
- IRWD 0.24
- ARMN 0.14
- MACD
- IRWD 0.07
- ARMN 0.00
- Stochastic Oscillator
- IRWD 82.35
- ARMN 83.74
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.